Previous studies have shown the amount of time a person has RA as a more important risk factor than the inflammation that accompanies it.
先前的研究已经证明一个人患类风湿性关节炎的时间量是比伴随它的炎症更为重要的危险因素。
And tumour necrosis factor antagonists possibly increases your chance of getting a form of blood cancer lymphoma, although this is anyway more common in people with RA.
和肿瘤坏死因子拮抗剂可能增加你的机会获得某种形式的血液癌症，虽然这是无论如何更多的共同在人民与核证登记机关。
Objective to approach the value of anti-cyclic citrullinated peptide antibody (CCP), Anti-keratin antibody (AKA), anti-RA33 and rheumatoid factor (RF) in the diagnosis of rheumatoid arthritis (ra).
目的探讨环瓜氨酸多肽(CCP)抗体、抗角蛋白抗体(aka)、类风湿因子(RF)和抗ra33抗体对类风湿性关节炎(RA)的临床应用价值。
This article reviews the effect of biotherapy in ra including tumor necrosis factor inhibitor, IL-1inhibitor, stem cell transplantation genetic therapy and so on.
本文综述了包括肿瘤坏死因子抑制剂、白细胞介素1抑制剂、干细胞移植及基因治疗等生物治疗在类风湿性关节炎治疗中的作用。
This article reviews the effect of biotherapy in ra including tumor necrosis factor inhibitor, IL-1inhibitor, stem cell transplantation genetic therapy and so on.
本文综述了包括肿瘤坏死因子抑制剂、白细胞介素1抑制剂、干细胞移植及基因治疗等生物治疗在类风湿性关节炎治疗中的作用。
应用推荐